MDL MD to MD Disease States, Clinical Applications & Referral Pathways
The PDF is a physician‑focused marketing and educational deck produced by MDLifespan. It frames the rising exposure to environmental toxins and chronic inflammation as a hidden health crisis linked to over 200 diseases, including cancer, neurodegeneration, cardiovascular disease, autism, and aging. The core intervention presented is a patent‑pending "Advanced Serial Therapeutic Plasma Exchange" (TPE) protocol that removes plasma, discards toxin‑laden plasma, and returns red cells with albumin, performed in 3‑5 serial sessions and combined with a proprietary oral supplement (MDL‑CLEAN) and avoidance training. The deck reports observed clinical outcomes such as 90‑100% removal of certain heavy metals, 96% reduction of microplastics, 40‑60% drop in inflammatory biomarkers, and improvements in cellular aging markers. It outlines a suite of disease‑specific protocols (MDL BRAIN, HEART, IMMUNITY, MOLD, ANTI‑CANCER, BABY, LONGEVITY, TOXIN) and lists the medical advisory team and a 2025 Medical Hypotheses article supporting the hypothesis that serial TPE plus supplementation reduces synthetic chemical burden. Referral pathways are described as a physician‑to‑physician model: identify patient, refer, evaluation, TPE treatment, and return to the referring provider. The deck also includes a patient‑education guide on toxin avoidance and a nationwide location map for MDLifespan clinics.
Topics
Environmental Toxins as a Hidden Health Crisis
Presentation of data linking widespread exposure to chemicals, heavy metals, microplastics, pesticides, and other synthetic compounds with chronic diseases such as cancer, neurodegeneration, cardiovascular disease, autism, and aging.
Rationale and Mechanism of Advanced Serial Therapeutic Plasma Exchange
Explanation of the patent‑pending TPE process: anticoagulation, centrifugation, plasma discard, RBC recombination with albumin, and repeat sessions (3‑5), combined with supplementation and avoidance training to reduce circulating toxins and inflammatory mediators.
Observed Clinical Outcomes and Biomarker Improvements
Quantitative results reported after serial TPE: heavy‑metal removal percentages, 96% microplastic reduction, 40‑60% inflammation drop, 75% oxidation decrease, 66% pre‑cancer cell reduction, and improvements in immune strength, metabolic markers, and cellular aging.
Proprietary Oral Supplement (MDL‑CLEAN) Composition and Role
Detailed ingredient list of the daily supplement taken for six months, including vitamins, minerals, amino acids, botanical extracts, and proprietary blends intended to support detoxification and tissue repair alongside TPE.
Disease‑Specific MDL Protocols and Targeted Benefits
Catalog of branded protocols (MDL BRAIN, HEART, IMMUNITY, MOLD, ANTI‑CANCER, BABY, LONGEVITY, TOXIN) each with a brief claim about toxin removal and health outcome for the respective organ system or condition.
Medical Advisory Team and Peer‑Reviewed Evidence
Listing of advisory physicians (neurologists, cardiologists, toxicologists, etc.) and citation of a 2025 Medical Hypotheses article co‑authored by Paul Savage, MD, presenting a hypothesis and pilot data that serial TPE plus supplementation reduces synthetic chemical levels.
Physician Referral Pathway and Partnership Model
Step‑by‑step workflow for referring physicians: patient identification, referral to MDLifespan, evaluation, serial TPE treatment, and return to the referring provider, emphasizing complementarity rather than replacement of care.
Patient Education on Toxin Avoidance and Lifestyle Changes
Guidance material authored by Paul Savage, MD, covering food, water, home, indoor air, plastics, and lifestyle recommendations to reduce ongoing toxin exposure, positioned as a companion to the TPE protocols.